drugset / Trial / NCT03645304

Postoperative Analgesic Efficacy of Continuous Wound Infusion After Laparoscopy

NCT03645304 ↗

Unknown 66 enrolled Kangbuk Samsung Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

Studies evaluating the effectiveness of continuous wound infusion (CWI) to manage postoperative pain following laparoscopy are markedly lacking. Especially, there was no study comparing CWI and placebo in treating gynecologic laparoscopy. Therefore, the investigators conducted this randomized, double-blind, placebo-controlled trial to investigate whether CWI of local anesthetics was an effective strategy for enhanced recovery after surgery (ERAS), compared with placebo in patients undergoing benign gynecologic laparoscopy.

Timeline

Start
2019-01-21
Primary completion
2020-04-03
Completion
2020-04-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 750 mg Other